- IHH Healthcare (SGX:Q0F)'s 9M24 PATMI (ex EI and MFRS 129) of MYR1.7bn was up 21% y-o-y on strong core performance, above expectations. 9M24 revenue grew 15% y-o-y (+24% fx neutral) to MYR18.1bn, led by strength across all segments.
- - Read this at SGinvestors.io -
Another quarter of sustained core growth
- The growth in IHH Healthcare’s core hospital and healthcare segment was attributed to sustained demand for healthcare services, higher revenue intensity, and inflation-adjusted price adjustments. 9M24 PATMI of MYR1.7bn was up 21% y-o-y, in part due to a lower effective tax rate of 12.6% (vs. 23.2% in 9M23) in relation to deferred tax credits at Acibadem.
- - Read this at SGinvestors.io -
Growth trajectory to continue with robust capital management measures in place.
- Read more at SGinvestors.io.
Above is the excerpt from report by DBS Group Research.
Clients of DBS may access the full report in PDF @ https://www.dbs.com/insightsdirect/.
Amanda TAN DBS Group Research | Andy SIM CFA DBS Group Research | https://www.dbs.com/insightsdirect/ 2024-12-02
Previous report by DBS:
2024-03-01 IHH Healthcare - Cruel Summer Is “Swift-ly” Over.
Price targets by 2 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
